Ducommun Inc. (NYSE:DCO) has been assigned an average rating of “Buy” from the seven brokerages that are currently covering the stock. One investment analyst has rated the stock with a sell rating, one has given a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $22.75.
A number of analysts have recently weighed in on the company. B. Riley reaffirmed a “buy” rating and set a $26.75 price objective on shares of Ducommun in a research report on Saturday, August 6th. FBR & Co reaffirmed a “buy” rating on shares of Ducommun in a research report on Friday, August 5th. Canaccord Genuity reaffirmed a “buy” rating and set a $25.00 price objective on shares of Ducommun in a research report on Sunday, August 7th. Finally, Zacks Investment Research raised Ducommun from a “hold” rating to a “strong-buy” rating and set a $24.00 price objective on the stock in a research report on Monday, August 8th.
Shares of Ducommun (NYSE:DCO) opened at 22.84 on Wednesday. The company’s market capitalization is $255.03 million. The stock has a 50 day moving average price of $22.55 and a 200-day moving average price of $18.92. Ducommun has a 12 month low of $12.28 and a 12 month high of $24.86.
Ducommun (NYSE:DCO) last announced its earnings results on Thursday, August 4th. The company reported $0.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.28 by $0.06. The company had revenue of $133.40 million for the quarter, compared to analyst estimates of $141.54 million. Ducommun had a positive return on equity of 3.45% and a negative net margin of 9.38%. The firm’s quarterly revenue was down 23.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.16 earnings per share. Analysts expect that Ducommun will post $1.43 earnings per share for the current fiscal year.
In other news, VP Rose F. Rogers sold 5,000 shares of the company’s stock in a transaction on Tuesday, September 6th. The stock was sold at an average price of $24.29, for a total transaction of $121,450.00. Following the sale, the vice president now owns 32,816 shares of the company’s stock, valued at $797,100.64. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 9.10% of the company’s stock.
Hedge funds have recently bought and sold shares of the company. First Manhattan Co. purchased a new position in shares of Ducommun during the second quarter worth approximately $113,000. Metropolitan Life Insurance Co. NY purchased a new position in shares of Ducommun during the second quarter worth approximately $175,000. American Financial Group Inc. purchased a new position in shares of Ducommun during the second quarter worth approximately $219,000. Emerald Mutual Fund Advisers Trust increased its position in shares of Ducommun by 24.9% in the second quarter. Emerald Mutual Fund Advisers Trust now owns 15,841 shares of the company’s stock worth $313,000 after buying an additional 3,159 shares during the last quarter. Finally, Nationwide Fund Advisors increased its position in shares of Ducommun by 106.3% in the second quarter. Nationwide Fund Advisors now owns 20,315 shares of the company’s stock worth $402,000 after buying an additional 10,469 shares during the last quarter. 79.41% of the stock is currently owned by institutional investors and hedge funds.
Ducommun Company Profile
Ducommun Incorporated is a global provider of engineering and manufacturing services for various products and applications used primarily in the aerospace, defense, industrial, natural resources, medical and other industries. The Company is a solution-based provider, offering a range of value-added products and services in its primary businesses of electronics, structures and integrated solutions.
Receive News & Ratings for Ducommun Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ducommun Inc. and related companies with MarketBeat.com's FREE daily email newsletter.